Src homology region 2 domain-containing phosphatase 1 positively regulates B cell receptor-induced apoptosis by modulating association of B cell linker protein with Nck and activation of c-Jun NH2-terminal kinase

J Immunol. 2002 Jul 15;169(2):778-86. doi: 10.4049/jimmunol.169.2.778.

Abstract

Src homology region 2 domain-containing phosphatase 1 (SHP-1) is a key mediator in lymphocyte differentiation, proliferation, and activation. We previously showed that B cell linker protein (BLNK) is a physiological substrate of SHP-1 and that B cell receptor (BCR)-induced activation of c-Jun NH(2)-terminal kinase (JNK) is significantly enhanced in cells expressing a form of SHP-1 lacking phosphatase activity (SHP-1-C/S). In this study, we confirmed that SHP-1 also exerts negative regulatory effects on JNK activation in splenic B cells. To further clarify the role of SHP-1 in B cells, we examined how dephosphorylation of BLNK by SHP-1 affects downstream signaling events. When a BLNK mutant (BLNK Delta N) lacking the NH(2)-terminal region, which contains four tyrosine residues, was introduced in SHP-1-C/S-expressing WEHI-231 cells, the enhanced JNK activation was inhibited. Among candidate proteins likely to regulate JNK activation through BLNK, Nck adaptor protein was found to associate with tyrosine-phosphorylated BLNK and this association was more pronounced in SHP-1-C/S-expressing cells. Furthermore, expression of dominant-negative forms of Nck inhibited BCR-induced JNK activation. Finally, BCR-induced apoptosis was suppressed in SHP-1-C/S-expressing cells and coexpression of Nck SH2 mutants or a dominant-negative form of SEK1 reversed this phenotype. Collectively, these results suggest that SHP-1 acts on BLNK, modulating its association with Nck, which in turn negatively regulates JNK activation but exerts a positive effect on apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Adjuvants, Immunologic / physiology
  • Animals
  • Apoptosis / immunology*
  • B-Lymphocytes / cytology
  • B-Lymphocytes / enzymology
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • Carrier Proteins / metabolism*
  • Carrier Proteins / physiology
  • Down-Regulation / immunology
  • Enzyme Activation / immunology
  • Intracellular Signaling Peptides and Proteins
  • JNK Mitogen-Activated Protein Kinases
  • Mice
  • Mice, Inbred C3H
  • Mice, Mutant Strains
  • Mitogen-Activated Protein Kinases / metabolism*
  • Mitogen-Activated Protein Kinases / physiology
  • Oncogene Proteins / metabolism*
  • Oncogene Proteins / physiology
  • Peptide Fragments / physiology
  • Phosphoproteins / metabolism*
  • Phosphoproteins / physiology
  • Protein Phosphatase 1
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
  • Protein Tyrosine Phosphatases / physiology*
  • Receptors, Antigen, B-Cell / physiology*
  • Spleen / cytology
  • Spleen / enzymology
  • Spleen / immunology
  • Tumor Cells, Cultured / cytology
  • Tumor Cells, Cultured / enzymology
  • Tumor Cells, Cultured / metabolism
  • Up-Regulation / immunology*
  • src Homology Domains / immunology*

Substances

  • Adaptor Proteins, Signal Transducing
  • Adjuvants, Immunologic
  • B cell linker protein
  • Carrier Proteins
  • Intracellular Signaling Peptides and Proteins
  • Nck protein
  • Oncogene Proteins
  • Peptide Fragments
  • Phosphoproteins
  • Receptors, Antigen, B-Cell
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • Protein Phosphatase 1
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
  • Protein Tyrosine Phosphatases
  • Ptpn6 protein, mouse